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William Osler once wrote, ‘‘The practice of medicine is an
art, based on science.’’ Never is this statement truer than in
the care of patients with HIV infection in the intensive care
unit (ICU) in the current era of combination antiretroviral
therapy (ART). In this issue of Intensive Care Medicine,
Barbierandcolleaguesdescribetheetiologiesandoutcomes
of acute respiratory failure in patients with HIV infection
over the ﬁrst decade of ART (1996–2000) [1]. Remarkably,
the etiology of respiratory failure was identiﬁed in[98%
of the 145 patients in the retrospective study. Bacterial
pneumonia was the most common cause, followed by
Pneumocystis pneumonia (PCP). Notably, non-invasive
ventilation averted the need for endotracheal intubation and
mechanical ventilation in 19 of 22 patients. To differentiate
between patients taking ART and patients only reporting
receipt of ART, the authors considered patients with evi-
dence of poor adherence (i.e., patients for whom medical
chart review indicated non-adherence with prescription of
ART,patientswithstationaryviralloadsandnoevidenceof
viral resistance,orpatientswhohadnotreceivedtherapyfor
[6 months) in the non-treatment group. Almost one-third
of patients were considered in the ART treatment group at
the time of ICU admission. Although not a statistically
signiﬁcant difference, patients receiving ART actually had
higher mortality (30%) compared to those not receiv-
ing ART (15%) (p = 0.07), despite having higher CD4
lymphocyte counts, lower HIV viral loads, and fewer
opportunisticinfections.Overallhospitalsurvivalwas80%,
was stable across the study period, and was not statistically
different across different etiologic groups.
The current study adds to the growing number of
studies of the critical care of patients with HIV infection
in the ART era. Following the introduction of HIV pro-
tease inhibitors and their use in combination with HIV
reverse transcriptase inhibitors in 1996, improved out-
comes were documented with ART among outpatients
[2]. A study from San Francisco General Hospital in the
early years of the ART era (1996–1999) provided
encouraging evidence that the protective inﬂuence of
ART might be extended to critically ill patients with HIV
infection [3]. The potential lifesaving role of ART led to
the consideration of its use during the period of acute
illness in the ICU, though this practice has remained
controversial [4]. At least one retrospective study inves-
tigated the effect of continuation of ART during ICU stay
and the effect of initiation of ART on ICU and 6-month
outcome; the authors concluded that 6-month survival
was associated with ART [5]. In addition, a recent multi-
center randomized controlled trial found that initiation of
ART during an acute opportunistic infection, rather than
deferring treatment, reduces progression of HIV disease
and mortality, although the study was not designed spe-
ciﬁcally to study critical illness [6].
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conferred by ART, several recent studies have found no
improvement in hospital or short-term survival between
patients receiving or not receiving ART at the time of
ICU admission [7–11]. Even when authors have not
attempted to deﬁne treatment adherence as in the current
study, investigators have noted higher CD4 lymphocyte
counts and lower viral loads among ART recipients [11].
Nevertheless, the current study and these prior studies
demonstrate the improved survival of critically ill patients
with HIV infection in the ART era.
Although ART has not been associated consistently
with this improved survival, one possible explanation is
the decreased percentage of patients admitted to the ICU
with PCP, a recognized risk factor for in-hospital mor-
tality among critically ill patients with HIV infection,
compared to the pre-ART era [12–14]. In the most recent
studies in a continuing series out of San Francisco Gen-
eral Hospital, ongoing since 1981, respiratory failure has
remained the most common indication for ICU admission,
and PCP has remained the most frequent etiology of
respiratory failure [3, 11]. However, the percentages have
decreased throughout the study period, presumably in part
due to prophylactic therapy and ART. In addition, several
studies have found that patients on ART were more likely
to have non-AIDS-related admissions, which has been
associated with improved survival [3, 7, 10, 11].
Nonetheless, the changing etiology of respiratory fail-
ure fails to explain completely the improved survival. The
current study and other ART era studies have demon-
strated improved survival even among patients with PCP
[9, 15–17]. Although infection with Pneumocystis was a
risk factor for in-hospital mortality in the current study,
survival exceeded 85%, similar to that in other recent
studies, and a striking improvement compared with the
earliest studies from the beginning of the HIV epidemic.
AdvancementsinICUcarethatareunrelatedtoHIVcare
may also explain the survival gains in the care of critically
ill patients with HIV infection, though studies designed to
determinetheindividualeffectsoftheseinterventionshave
been limited. For example, the current ART era has coin-
cided with the adoption of low tidal volume ventilation
[18],intensiveinsulintherapy[19],andearlygoal-directed
therapy for sepsis [20]. In the current study, the authors
hypothesizedthatearlytransferofpatientstotheICU,non-
invasive ventilation for PCP, and aggressive management
of sepsis contributed to the high in-hospital survival,
independent of ART or its effects (i.e., ICU admission
diagnosis or CD4 cell count). Therefore, improvements in
ICU practice remain a plausible contributing factor.
Unfortunately, the current study and many of its con-
temporary comparisons have considered only hospital
survival, not longer term survival. Therefore, the well-
recognized beneﬁts that ART exerts over periods longer
than typical ICU stays cannot be excluded.
Regardless, in the absence of prospective, ICU-based
randomized clinical trials, retrospective observational
studies such as the current study can provide useful
clinical information to inform clinicians. Despite the
inconsistent ﬁndings of the inﬂuence of ART on the
outcome of critically ill patients with HIV infection, this
study and others reinforce key points. First, in-hospital
survival for these critically ill patients has improved in the
current ART era. Second, the etiologic spectrum of
respiratory failure, as well as indication for ICU admis-
sion, has shifted. Therefore, clinicians should remain
vigilant for both non-HIV-associated and HIV-associated
conditions, including the side effects of ART (such as
drug interactions or immune reconstitution syndrome)
among critically ill patients with HIV infection.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are
credited.
References
1. Barbier F, Coquet I, Legriel S, Pavie J,
Darmon M, Mayaux J, Molina J-M,
Schlemmer B, Azoulay E (2009)
Etiologies and outcome of acute
respiratory failure in HIV-infected
patients. J Intensive Care Med.
doi:10.1007/s00134-009-1559-4
2. Palella FJ Jr, Delaney KM, Moorman
AC, Loveless MO, Fuhrer J, Satten GA,
Aschman DJ, Holmberg SD (1998)
Declining morbidity and mortality
among patients with advanced human
immunodeﬁciency virus infection: HIV
outpatient study investigators. N Engl J
Med 338:853–860
3. Morris A, Creasman J, Turner J, Luce
JM, Wachter RM, Huang L (2002)
Intensive care of human
immunodeﬁciency virus-infected
patients during the era of highly active
antiretroviral therapy. Am J Respir Crit
Care Med 166:262–267
4. Huang L, Quartin A, Jones D, Havlir
DV (2006) Intensive care of patients
with HIV infection. N Engl J Med
355:173–181
5. Croda J, Croda MG, Neves A, Sousa
De, dos Santos S (2009) Beneﬁt of
antiretroviral therapy on survival of
human immunodeﬁciency virus-
infected patients admitted to an
intensive care unit. Crit Care Med
37:1605–1611
6. Zolopa A, Andersen J, Powderly W,
Sanchez A, Sanne I, Suckow C, Hogg
E, Komarow L (2009) Early
antiretroviral therapy reduces AIDS
progression/death in individuals with
acute opportunistic infections: a
multicenter randomized strategy trial.
PLoS One 5:e5575
16607. Narasimhan M, Posner AJ, DePalo VA,
Mayo PH, Rosen MJ (2004) Intensive
care in patients with HIV infection in
the era of highly active antiretroviral
therapy. Chest 125:1800–1804
8. Khouli H, Afrasiabi A, Shibli M, Hajal
R, Barrett CR, Homel P (2005)
Outcome of critically ill human
immununodeﬁciency virus-infected
patients in the era of highly active
antiretroviral therapy. J Intensive Care
Med 20:327–333
9. Miller RF, Allen E, Copas A, Singer M,
Edwards SG (2006) Improved survival
for HIV infected patients with severe
Pneumocystis jirovecii pneumonia is
independent of highly active
antiretroviral therapy. Thorax 61:716–
721
10. Dickson SJ, Batson S, Copas AJ,
Edwards SG, Singer M, Miller RF
(2007) Survival of HIV-infected
patients in the intensive care unit in the
era of highly active antiretroviral
therapy. Thorax 62:964–968
11. Powell K, Davis JL, Morris A, Chi A,
Bensley MR, Huang L (2009) Survival
for patients with HIV admitted to the
ICU continues to improve in the current
era of combination antiretroviral
therapy. Chest 139:11–17
12. Wallace JM, Hansen NI, Lavange L,
Glassroth J, Browdy BL, Rosen MJ,
Kvale PA, Mangura BT, Reichman LB,
Hopewell PC (1997) Respiratory
disease trends in the pulmonary
complications of HIV infection study
cohort. Pulmonary complications of
HIV infection study group. Am J Respir
Crit Care Med 155:72–80
13. Nickas G, Wachter RM (2000)
Outcomes of intensive care for patients
with human immunodeﬁciency virus
infection. Arch Intern Med 160:541–
547
14. Vincent B, Timsit JF, Auburtin M,
Schortgen F, Bouadma L, Wolff M,
Regnier B (2004) Characteristics and
outcomes of HIV-infected patients in
the ICU: impact of the highly active
antiretroviral treatment era. J Intensive
Care Med 30:859–866
15. Curtis JR, Yarnold PR, Schwartz DN,
Weinstein RA, Bennett CL (2000)
Improvements in outcomes of acute
respiratory failure for patients with
human immunodeﬁciency virus-related
Pneumocystis carinii pneumonia. Am J
Respir Crit Care Med 162:393–398
16. Davis JL, Morris A, Kallet RH, Powell
K, Chi AS, Bensley M, Luce JM,
Huang L (2008) Low tidal volume is
associated with reduced mortality in
HIV-infected patients with acute lung
injury. Thorax 63:988–993
17. Fei MW, Sant CA, Kim EJ, Swartzman
A, Davis JL, Jarlsberg LG, Huang L
(2009) Severity and outcomes of
pneumocystis pneumonia in patients
newly diagnosed with HIV infection: an
observational cohort study. Scand J
Infect Dis 11:1–7
18. Acute Respiratory Distress Network
(2000) Ventilation with lower tidal
volumes as compared with traditional
tidal volumes for acute lung injury and
the acute respiratory distress syndrome.
N Engl J Med 342:1301–1308
19. Rivers E, Nguyen B, Havstad S, Ressler
J, Muzzin A, Knoblich B, Peterson E,
Tomlanovich M (2001) Early goal-
directed therapy collaborative group.
Early goal-directed therapy in the
treatment of severe sepsis and septic
shock. N Engl J Med 345:1368–1377
20. van den Berghe G, Wouters P, Weekers
F, Verwaest C, Bruyninckx F, Schetz
M, Vlasselaers D, Ferdinande P,
Lauwers P, Bouillon R (2001) Intensive
insulin therapy in the critically ill
patients. N Engl J Med 345:1359–1367
1661